Is the cardiovascular system a therapeutic target for cannabidiol?
Subject: Heart Disease - PUBLISHED VIA British Pharmacological Society
View Source >>
Stanley CP, Hind WH, O'Sullivan SE
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Published via American Journal of Physiology
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Published via British Journal of Pharmacology
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Published via Author Manuscript
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.
Published via Journal of Cardiovascular Pharmacology and Therapeutics
Published via BMJ Publishing Group Limited